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Abstract
Background: Nonstructural protein 1 (NS1) Ag-based tests are useful for detecting dengue virus (DENV), but there is lack
of evidence on the diagnostic accuracy of NS1 Ag-based tests in Asian population. Thus, we conducted this meta-analysis
to obtain the overall estimated and summarized performance of the NS1 Ag-based tests in the detection of DENV in Asia.
Methods: PubMed, Embase and Medline were searched for studies that evaluated the diagnostic validity of NS1 Ag-based
tests between January 1990 and November 2014. Data were analyzed by Meta-Disc and STATA software.
Results: A total of 18 studies including 3342 dengue cases and 1904 control cases which fulfilled the inclusion criteria
were considered for analysis. The pooled sensitivity and specificity for NS1 Ag-based tests was 66 % (95 % CI 64.5–67.5)
and 97.9 % (95 % CI 97.3–100), respectively. STRIP has the overall highest sensitivity (72.9 %, 95 % CI 70.1–75.5).
According to viral serotype, the test with the highest sensitivity for DENV1, DENV2 and DENV3 were Platelia (83.7 %, 95
% CI 79.7–87.1), Panbio (71.8 %, 95 % CI 65.5–80.9) and STRIP (81.9 %, 95 % CI 75.5–87.2) respectively. The highest
sensitivity for primary infection was Platelia (95.1 %, 95 % CI 92.6–96.9) and for secondary infection was STRIP
(64 %, 95 % CI 53.2–73.9).
Conclusion: Our meta-analysis suggests that NS1 Ag-based test is a good diagnostic method for DENV with a high
specificity. However, viral serotype, serological status, clinical severity and the duration of illness are the main factors
influencing the diagnostic accuracy.
Backgroud
Dengue, a vector-borne disease, has become one of the
most serious public problems due to the increasing mor-
bidity, with over one billion people at risk in tropical
and subtropical areas [1]. Dengue virus (DENV), genus
flavivirus, is antigenically classified into four serotypes
(DENV1-4). DENV is an arbovirus, mainly transmitted
by aedesaegypti mosquitoes. The virus is thought to be
responsible for close to 400 million infections per year
worldwide [2].
The World Health Organization (WHO) 2009 guide-
lines identified three diagnostic tests as golden standards
for dengue diagnosis: viral isolation and identification,
nucleotide detection, and serological tests for IgM or
IgGseroconversion [3]. However, these methods have cer-
tain limitations. For example, viral isolation is difficult to
perform and time-consuming. Nucleotide detection such
as RT-PCR requires specialized laboratory equipments.
And serological tests for IgM or IgG cannot be used for
early onset diagnosis. Therefore, a more efficient and ac-
curate detection method for DENV is warranted. Non-
structural protein 1 (NS1) is a glycoprotein that is
abundantly produced by DENV in the early stage of infec-
tion, and can be detected in the serum [4, 5]. In contrast
to IgM, which can only be detected at the beginning of
the fifth day of the disease, NS1 antigen capture could be
performed at the onset of symptoms.
Currently, several laboratory methods based on the cap-
ture of DENV NS1 antigen are available. The two main
methods for detecting DENV infection are enzyme-linked
immunosorbent assay (ELISA) (Platelia (Platelia Dengue
NS1 Ag-ELISA Kit) and Panbio (Panbio Dengue Early
ELISA Kit)) and immunochromatography (IC) (STRIP,
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Dengue NS1 Ag STRIP Kit). Previous studies have per-
formed meta-analysis of the diagnostic accuracy of NS1
Ag-based tests including all published articles, however,
there is still lack of evidence on the diagnostic accuracy of
NS1 Ag-based tests in Asian population. Therefore, we
conducted a meta-analysis to obtain the overall estimated
and summarized performance of NS1 Ag-based tests in
the detection of DENV in Asia.
Methods
Search strategy and inclusion criteria
A literature search was performed to screen studies in hu-
man that focused on the diagnostic performance of NS1 for
the detection of Dengue. We searched PubMed, Medline
and Embase database for relevant citations published in
English from January 1990 to November 2014. The key-
words “NS1” and “Dengue” were used. Two reviewers inde-
pendently reviewed each publication. The abstracts were
read to identify potentially eligible articles and then the full
texts of these articles were examined to determine whether
they should be included in our study. Any disagreement
was discussed and solved by a third reviewer. The inclusion
criteria were: (1) samples or patients with dengue con-
firmed by the standard methods including viral isolation
and identification, RNA detection, or serological test for
IgM and/or IgG; (2) samples or patients with dengue inves-
tigated by NS1 Ag-based capture methods; (3) have re-
ported sufficient data to allow us to calculate the true
positive (TP), false negative (FN), false positive (FP) and
true negative (TN) values; (4) at least 20 samples from pa-
tients and control group, respectively; (5) the participants
were Asian. Studies with an overlapping patients sample
were excluded.
Data extraction and quality assessment
The following information from each study was ex-
tracted independently by two reviewers: (1) first author
name; (2) year of publication; (3) location of studies; (4)
Fig. 1 Flow diagram of the studies identified
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number of patients; (5) detection methods; (6) event
numbers in TP, FN, TN and FP arms. QUADAS ques-
tionnaire was used to assess the quality of the studies in-
cluded in this meta-analysis.
Data analysis
The pooled sensitivity, specificity, diagnostic odds ratio
(DOR) and the likelihood ratios (positive likelihood ratio
(PLR) and negative likelihood ratio (NLR)) for single test
were calculated by Meta-Disc version 1.4. The DOR was
calculated as PLR/NLR. A hierarchical summarized re-
ceiver operating characteristic (HSROC) curve was plot-
ted by the software. We also constructed the area under
curve (AUC) that serves a global measure of the test
performance.
The I-squared value (I2) was used to assess the stat-
istical heterogeneity among the studies. The estimate
below 25 % was regarded as low heterogeneity, while
above 75 % was labeled as high heterogeneity [6]. If
heterogeneity existed, a random effect model was
used for meta-analysis; otherwise, a fixed effect model
was chosen. Subgroup analyses were performed according
to the detection methods (ELISA vs. IC), the manufac-
turers of the test kit, DENV serotypes, serological status,
clinical severity and days after onset of fever to assess po-
tential sources of variation in the study results.
In addition, a meta-regression was used according
to the following pre-defined characteristics to explore
the source of heterogeneity in the studies: study de-
sign, publication year, origin of sample, and sample
size. A p-value of < 0.05 was considered to be statisti-
cally significant. To assess potential publication bias,
the Deeks funnel plot asymmetry test was used, with
p < 0.05 indicating the presence of publication bias
[7]. Fagan nomograms, a two-dimensional graphical
tool for estimating how much the result of a diagnos-
tic test changes the probability that a patient has a




A total of 143 citations were obtained via database
searches, and eighteen met the inclusion criteria for this
study (Fig. 1). These studies included 3342 dengue cases
and 1904 control cases. Among the dengue cases, 439
patients had dengue hemorrhagic fever (DHF). 3129
samples were tested by Platelia Dengue NS1 Ag-ELISA
Kit (Bio-Rad), 1081 samples by Early Dengue NS1 ELISA
Kit (Pan-bio), and 1896 samples by Dengue NS1 Ag
STRIP (Bio-Rad) (Table 1).
Overall accuracy of the tests
The overall sensitivity and specificity of NS1 Ag-based
test kits were 66 % (95 % CI 64.5–67.5) and 97.9 % (95
Table 1 Summary of the included studies






Hermann [8] 2014 Thailand 4–12 152/182 159 141 20 1–7 RT-PCR/ELISA ELISA(Bio-Rad)
Gan [9] 2014 Singapore 18–68 193/53 147 NR 50 1–14 IgG/ELISA ELISA(Bio-Rad)
Naz [10] 2014 Pakistan 2–65 96/88 142 NR 42 2–7 IgG/ELISA Strip(Bio-Rad)
Aryati [11] 2013 Indonesia NR NR 188 NR 252 NR VI/RT-PCR ELISA(Panbio)
Huang [12] 2013 Taiwan 32–60 175/217 392 NR 50 1–8 VI/RT-PCR Strip(Bio-Rad)
Kosasih [13] 2013 Indonesia 4–53 142/78 220 NR 55 1–7 RT-PCR/ELISA ELISA(Bio-Rad)
Blacksell [14] 2012 Thailand NR NR 239 NR 50 NR RT-PCR/ELISA ELISA(Bio-Rad)
Watthanaworawita [15] 2011 Thailand >15 98/64 72 NR 90 1–7 RT-PCR/ELISA ELISA(Panbio)
Duong [16] 2011 Cambodia 4–11 203/136 101 87 139 3–8 VI/RT-PCR/ELISA ELISA(Bio-Rad)
Chuansumrit [17] 2011 Thailand <18 NR 19 36 30 2–10 VI/ ELISA ELISA(Bio-Rad)/Strip(Bio-Rad)
Blacksell [18] 2011 Sri Lanka NR NR 239 NR 148 NR RT-PCR/ELISA ELISA(Bio-Rad, panbio)/Strip(Bio-Rad)
Fry [19] 2011 Vietnam 3–15 NR 198 NR 100 1–4 RT-PCR/ELISA Strip(Bio-Rad)
Pok [20] 2010 Singapore NR NR 161 NR 160 1–8 RT-PCR/ELISA Strip(Bio-Rad)
Hang [21] 2009 Vietnam 4–42 62–76 125 NR 13 1–10 RT-PCR/ELISA ELISA(Panbio)
Zainah [22] 2009 Malaysia NR NR 100 NR 219 NR VI/RT-PCR Strip(Bio-Rad)
Blacksella [23] 2008 Vientiane NR NR 38 NR 54 NR ELISA ELISA(Panbio)
Lapphra [24] 2008 Thailand 3–52 132/103 151 19 64 1–5 VI/RT-PCR/ELISA ELISA(Bio-Rad)
Kumarasamy [25] 2007 Malaysia NR NR 213 NR 368 NR VI/RT-PCR ELISA(Bio-Rad)
NR no report, VI virus isolation, ELISA enzyme linked immunosorbent assay, DF dengue fever, DHF dengue hemorrhagic fever
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% CI 97.3–100), respectively. The sensitivity of NS1 Ag-
based test kits in primary infection patients was 88 %
(95 % CI 85.8–89.9) and in secondary infection patients
was 60.8 % (95 % IC 57.8–63.8). According to the DENV
serotypes, DENV1 had the highest sensitivity of 79.5 %
(95 % CI 76.6–82.3) and DENV4 had the lowest sensitiv-
ity of 46 % (95 % CI 36–59.3). The AUC (Area Under
ROC Curve) was 0.96. According to clinical severity and
test assays, NS1 Ag-based test kits were more effective
in diagnosing dengue fever (DF) than DHF, and IC had a
higher sensitivity than ELISA (Table 2).
Accuracy of the tests on the viral serotype, serological
status and clinical severity
Among the included studies, eleven used Platelia, five
usedPanbio and seven used Strip. For Platelia, the
sensitivity and specificity were 66.2 % (95 % CI 64.1–
68.2) and 97.3 % (95 % CI 96.1–98.2), respectively.
The values for Panbio were 54 % (95 % CI 50.1–57.9)
and 97.2 % (95 % CI 95.2–98.6), and the values for
Strip were 72.9 % (95 % CI 70.1–75.5) and 99.1 % (95
% CI 98.2–99.6), respectively. The AUCs of Platelia,
Panbio and Strip were 0.97, 0.96 and 0.98, respect-
ively (Table 3).
When evaluating the accuracy of these tests for
DENV1, the sensitivity of Platelia was 83.7 % (95 % CI
79.7–87.1), while the value for Panbio was 73.7 % (95 %
CI 65.5–80.9) and the value for Strip was 72.9 % (95 %
CI 70.1–75.5). For DENV2, the pooled sensitivity was
56.9 % (95 % CI 51.9–61.8) for Platelia, 71.8 % (95 % CI
65.5–80.9) for Panbio and 69 % (95 % CI 63–74.5) for
Strip. For DENV3, the pooled sensitivity was 69.9 % (95
% CI 64.8–74.6) for Platelia, 63.3 % (95 % CI 48.3–76.6)
for Panbio and 81.9 % (95 % CI 75.5–87.2) for Strip. For
DENV4, the pooled sensitivity was 42.9 (95 % CI 32.1–
54.1) for Platelia (Table 3).
Regarding the classification of primary or secondary
dengue infection, the sensitivities of Platelia, Panbio
and Strip were 95.1 % (95 % CI 92.6–96.9), 72.6 %
(95 % CI 65.6–78.9) and 87.3 % (95 % CI 83.6–90.5)
for primary infection, and 63 % (95 % CI 59.5–66.4),
50.8 % (95 % CI 43.5–58) and 64 % (95%CI 53.2–
73.9) for secondary infection, respectively (Table 3).
To verify whether such tests had significant variations
in the performance in patients with DF or DHF, we per-
formed subgroup analysis according to clinical severity,
and the results showed that the pooled sensitivity of
Platelia was 58.7 % (95 % CI 52.7–64.5) for DF, and
72.1 % (95 % CI 67.6–76.3) for DHF (Table 3).
Accuracy of the tests on illness duration
We also evaluated the influence of the illness duration
on the accuracy of the NS1 Ag-based tests. It was found
that the sensitivity of the tests was higher in the first
3 days after the illness onset than in the following 4–
7 days (Table 4).
Post-test probability and publication bias
To obtain the post-test probability, we used Fagan’s
nomogram to perform a simulation of an environment
that had a prevalence of 42.9 % for dengue disease, an
estimate that was generated based on the studies se-
lected. Thus, the probability for someone that had the
disease but was not detected by Platelia was 18 % in this
model (Fig. 2a). Similarly, the value for Panbio was 25 %,
and the value for Strip was 15 % (Fig. 2b-c). In contrast,
the post-test probability of sick patient with a positive
test result was 99 % for Platelia, 100 % for Panbio, and
98 % for Strip (Fig. 2a-c).
Additionally, the Deeks funnel plot did not show
any potential publication bias for the subgroup studies
(PPlatelia = 0.95, PPanbio = 0.17 and PStrip = 0.51).
Discussion
The dramatic increase in Asian dengue burden has pro-
moted social interest in improving dengue diagnosis. Al-
though many dengue vaccines are under development,
none has been licensed to date. Therefore, early diagnosis
of dengue leads to appropriate clinical management and
better outcome. Soluble NS1 detection in the serum or
plasma of a DENV-infected patient is a novel method for
early dengue diagnosis. To evaluate the accuracy of NS1




Sensitivity % Specificity % Heterogeneity%
(95 % CI) (95 % CI) (I2)
Overall 18 66 (64.5–67.5) 97.9 (97.3–100) 82.6
Serological status
Primary 9 88 (85.8–89.9) 89.2
Secondary 10 60.8 (57.8–63.8) 93.2
DENV serotypes
DENV-1 10 79.5 (76.6–82.3) 81
DENV-2 11 62.7 (59.1–66.2) 84.2
DENV-3 10 73 (69.2–76.6) 79.5








5 58.8 (54–63.4) 71.6
NS1 test assays
ELISA 14 63.3 (61.5–65.1) 94.9
IC 7 72.9 (70.1–75.5) 90.8
Shan et al. BMC Infectious Diseases 2015, 15: Page 4 of 8
http://www.biomedcentral.com/1471-2334/15/1/
Table 3 Diagnostic accuracy results of the NS1 Ag-based tests on the viral serotype, serological status and clinical severity
ELISA IC
Platelia Panbio Overall Strip
Overall
No. of study 11 5 14 7
Sensitivity % (95 % CI) 66.2 (64.1–68.2) 54 (50.1–57.9) 63.3 (61.5–65.1) 72.9 (70.1–75.5)
Specificity % (95 % CI) 97.3 (96.1–98.2) 97.2 (95.2–98.6) 97.3 (96.3–98.1) 99.1 (98.2–99.6)
Heterogeneity % (I2) 84.1 79.8 82.4 40.5
DENV serotypes
DENV1
No. of study 7 2 8 3
Sensitivity % (95 % CI) 83.7 (79.7–87.1) 73.7 (65.5–80.9) 81.2 (77.7–84.4) 75.9 (70.1–81)
Heterogeneity % (I2) 82.5 89.6 84 57.8
DENV2
No. of study 7 2 8 4
Sensitivity % (95 % CI) 56.9 (51.9–61.8) 71.8 (60.5–81.4) 59.3 (54.8–63.7) 69 (63–74.5)
Heterogeneity % (I2) 88.6 0 86.4 70.4
DENV3
No. of study 6 2 7 4
Sensitivity % (95 % CI) 69.9 (64.8–74.6) 63.3 (48.3–76.6) 69.1 (64.3–73.5) 81.9 (75.5–87.2)
Heterogeneity % (I2) 82.3 15.3 76.9 75.5
DENV4
No. of study 4 0 4 0
Sensitivity % (95 % CI) 42.9(32.1–54.1) 42.9 (32.1–54.1)
Heterogeneity % (I2) 57.1 57.1
Serological status
Primary
No. of study 7 2 8 2
Sensitivity % (95 % CI) 95.1 (92.6–96.9) 72.6 (65.6–78.9) 88.4 (85.7–90.8) 87.3 (83.6–90.5)
Heterogeneity % (I2) 56.8 29.2 89.1 94.6
Secondary
No. of study 7 3 9 2
Sensitivity % (95 % CI) 63 (59.5–66.4) 50.8 (43.5–58) 60.6 (57.4–63.6) 64 (53.2–73.9)
Heterogeneity % (I2) 95.8 0 94.1 88.1
Clinical severity
Dengue Fever
No. of study 4 1 5 1
Sensitivity % (95 % CI) 72.1 (67.6–76.3) 51 (37–64) 69.5 (65.2–73.6) 89 (67–99)
Heterogeneity % (I2) 73.9 81.7
Dengue Hemorrhagic Fever
No. of study 4 1 5 1
Sensitivity % (95 % CI) 58.7 (52.7–64.5) 58.7 (49–67) 58.6 (53.6–63.4) 61 (43–77)
Heterogeneity % (I2) 82.9 77.2
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Ag-based test in dengue diagnosis, we performed a meta-
analysis using published studies.
Our results indicated that NS1 Ag-based test has a
high accuracy for dengue diagnosis. The AUC of NS1
Ag-based test was 0.96. The pooled specificity (97.9 %,
95 % CI 97.3–100) was extremely high, but the pooled
sensitivity (66 %, 95 % CI 64.5–67.5) was relatively low.
In this regard, NS1 Ag-based test may not be suitable to
detect dengue as low sensitivity may result in misdiag-
nosis. Considering that the sensitivity of NS1 Ag-based
test may be influenced by test method, viral serotype,
serological status and clinical severity, we also performed
subgroup analysis. According to the analysis of the dif-
ferent kits (Platebia, Panbioand STRIP), it appeared that
Dengue NS1 Ag STRIP Kit had the higher sensitivity,
followed by Platebia Dengue NS1 Ag-ELISA Kit.
Our meta-analysis showed that NS1 Ag-based test had
a lower sensitivity for DENV4 and a higher sensitivity
for DENV1 and DENV3. According to the analysis of
the different kits, Platebia had the highest sensitivity for
DENV1, Panbio had the highest sensitivity for DENV2,
and STRIP had the highest sensitivity for DENV3. Un-
fortunately, the sensitivity data for DENV4 was not
available for Panbio and STRIP, thus we were unable to
compare the sensitivity of the three kits for DENV4. The
reason for the wide range of total accuracy of serotyping
for dengue may be due to the quantitative differences in
the secreted NS1 by the different viral serotypes. How-
ever, this hypothesis needs to be confirmed by additional
studies.
It was shown that the sensitivity of NS1 Ag-based test
was higher for primary dengue infection than secondary
infection. For patients with primary dengue infection,
Platelia had the highest sensitivity. As for secondary in-
fection, STRIP had the highest sensitivity. Detection of
NS1 antigen in secondary infection may be hampered by
a rapid rise in antibody levels due to the anamnestic
antibody response [26], which leads to the formation of
immune complexes and thus preventing the binding of
capture or detection antibodies to NS1 antigen. How-
ever, simple and repeat hit of secondary DENV infected
patients’ serums was shown to be very useful for increas-
ing the sensitivity of the DENV NS1 Ag-based test. In
addition, our results also revealed a small decrease of
sensitivity of the NS1 Ag-based test for patients with DF
compared to those with DHF. Moreover, the sensitivity
Table 4 Diagnostic accuracy results of the NS1 Ag-based test on illness duration
1–3 day 4–7 day
No. of study Sensitivity % (95 % CI) Heterogeneity % (I2) No. of study Sensitivity % (95 % CI) Heterogeneity % (I2)
NS1 5 79.7 (75.2–83.8) 76.4 4 57.8 (53.3–62.3) 82.4
Fig. 2 Fagan’s nomogram for the calculation of post-test probabilities. A pre-test probability of 42.9 % for dengue disease was fixed, which was estimated
using the number of symptomatic cases in the selected studies. a Platelia had a post-test probability of 99 %. b For Panbio kits, post-test probability was
100 %. c Strip had a post-test probability of 98 %, ie, with an estimated prevalence of 37 %, if this patient tests positive, the post-test probability that he/
she truly has dengue would be 98 % (solid line). On the other hand, if patient tests negative, the post-test probability that he/she truly has dengue would
be 18 % (a), 25 % (b) or 15 % (c) (dotted line)
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of NS1 Ag-based test was higher in the first 3 days after
illness onset than in the following 4–7 days, and again,
the increased antibodies generated by the host’s immune
response could be the reason.
There was significant heterogeneity in this meta-
analysis and caution must be taken when interpreting
the results. In addition, we have used meta-regression
analysis to explore the potential factors that may be the
source of the heterogeneity. Unfortunately, none of the
covariates examined was the source of heterogeneity.
Further studies were needed to identify the potential
source for the heterogeneity.
There were also some limitations in our study. Firstly,
the standard diagnosis methods of NS1 were different in
the included studies, e.g., some studies used viral culture
while others used serological test as standard method.
Secondly, only a few authors used other types of fever as
control samples, while most used samples from healthy
persons as control. Thirdly, data were not divided into
groups based on gender, age or other variables, due to
the limited studies. Despite these limitations, we believe
that our analysis could contribute to the evaluation of
the accuracy of NS1 Ag-based test, which eventually
might help the clinical decision making process.
Conclusion
Our meta-analysis suggests that NS1 Ag-based test was
a good diagnosis method for dengue with a high specifi-
city. However, viral serotype, serological status, clinical
severity and illness duration were the main factors influ-
encing the diagnosis accuracy. Moreover, the different
test kits have their own advantages/disadvantages. Large,
multicenter prospective studies are needed to confirm
our results.
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